Home Cart 0 Sign in  

[ CAS No. 308831-94-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 308831-94-9
Chemical Structure| 308831-94-9
Structure of 308831-94-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 308831-94-9 ]

Related Doc. of [ 308831-94-9 ]

Alternatived Products of [ 308831-94-9 ]

Product Details of [ 308831-94-9 ]

CAS No. :308831-94-9 MDL No. :MFCD31806862
Formula : C24H22F2N2O6S Boiling Point : -
Linear Structure Formula :- InChI Key :VEQKKZQAOCWPKO-UHFFFAOYSA-N
M.W : 504.50 Pubchem ID :18324799
Synonyms :

Calculated chemistry of [ 308831-94-9 ]

Physicochemical Properties

Num. heavy atoms : 35
Num. arom. heavy atoms : 17
Fraction Csp3 : 0.25
Num. rotatable bonds : 11
Num. H-bond acceptors : 8.0
Num. H-bond donors : 0.0
Molar Refractivity : 129.53
TPSA : 129.9 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.23 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.93
Log Po/w (XLOGP3) : 5.84
Log Po/w (WLOGP) : 6.94
Log Po/w (MLOGP) : 3.82
Log Po/w (SILICOS-IT) : 4.73
Consensus Log Po/w : 5.05

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -6.28
Solubility : 0.000264 mg/ml ; 0.000000524 mol/l
Class : Poorly soluble
Log S (Ali) : -8.34
Solubility : 0.00000231 mg/ml ; 0.0000000046 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -7.55
Solubility : 0.0000144 mg/ml ; 0.0000000284 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 4.13

Safety of [ 308831-94-9 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P201-P202-P261-P281-P305+P351+P338-P308+P313 UN#:2811
Hazard Statements:H302-H315-H319-H335-H350 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 308831-94-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 308831-94-9 ]

[ 308831-94-9 ] Synthesis Path-Downstream   1~32

  • 1
  • ethyl 2-[(ethoxycarbonyl)amino]-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate [ No CAS ]
  • [ 697-73-4 ]
  • [ 308831-94-9 ]
YieldReaction ConditionsOperation in experiment
79% With potassium iodide; potassium carbonate; In N,N-dimethyl-formamide; Reference Example 10 Ethyl 2-[N-(2,6-difluorobenzyl)-N-ethoxycarbonylamino]-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate To a solution of the compound obtained in Reference Example 9 (490 mg, 1.30 mol) in N,N-dimethylformamide (20 ml) were added potassium carbonate (196 mg, 1.42 mol), potassium iodide (236 mg, 1.42 mol) and 2,6-difluorobenzyl chloride (232 mg, 1.42 mmol), and the mixture was stirred at room temperature for 5 hours. This reaction mixture was concentrated and the residue was partitioned between chloroform and aqueous sodium chloride solution. The aqueous layer was extracted with chloroform. The organic extracts were combined and washed with aqueous sodium chloride solution and dried (MgSO4) and the solvent was distilled off under reduced pressure. The residue was chromatographed on silica gel and the amorphous powder obtained was recrystallized from methanol to give the title compound as yellow powdery crystals (520 mg, 79%). mp: 91-92 C.; 1H-NMR (300 MHz, CDCl3) delta: 1.15-1.35 (6H, m), 2.40 (3H, s), 4.15-4.29 (4H, m), 4.97 (2H, s), 6.86 (2H, t, J=7.8 Hz), 7.25-7.32 (1H, m), 7.51 (2H, d, J=8.8 Hz), 8.25 (2H, d). IR (KBr): 1717, 1597, 1524, 1475, 1392, 1348 cm-1.
79% With potassium carbonate; potassium iodide; In DMF (N,N-dimethyl-formamide); at 15 - 25℃; for 5.0h; To a solution of the compound obtained in Reference Example 9 (490 mg, 1.30 mol) in N,N-dimethylformamide (20 ml) were added potassium carbonate (196 mg, 1.42 mol), potassium iodide (236 mg, 1.42 mol) and 2,6-difluorobenzyl chloride (232 mg, 1.42 mmol), and the mixture was stirred at room temperature for 5 hours. This reaction mixture was concentrated and the residue was partitioned between chloroform and aqueous sodium chloride solution. The aqueous layer was extracted with chloroform. The organic extracts were combined and washed with aqueous sodium chloride solution and dried (MgSO4) and the solvent was distilled off under reduced pressure. The residue was chromatographed on silica gel and the amorphous powder obtained was recrystallized from methanol to give the title compound as yellow powdery crystals (520 mg, 79%). mp: 91-92 C. 1H-NMR (300 MHz, CDCl3) delta: 1.15-1.35 (6H, m), 2.40 (3H, s), 4.15-4.29 (4H, m), 4.97 (2H, s), 6.86 (2H, t, J=7.8 Hz), 7.25-7.32 (1H, m), 7.51 (2H, d, J=8.8 Hz), 8.25 (2H, d). IR (KBr): 1717, 1597, 1524, 1475, 1392, 1348 cm-1.
  • 2
  • [ 308831-94-9 ]
  • [ 308831-95-0 ]
YieldReaction ConditionsOperation in experiment
100% With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile); In tetrachloromethane; at 100℃; for 2.0h; A mixture of the compound obtained in Reference Example 10 (20 g, 39.64 mol), N-bromosuccinimide (7.76 g, 43.60 mol), alpha,alpha'-azobisisobutyronitrile (0.72 g, 4.36 mol) and carbon tetrachloride (300 ml) was stirred at 100 C. for 2 hours.. After cooling, this reaction mixture was washed with aqueous sodium chloride solution and dried (MgSO4) and the solvent was distilled off under reduced pressure.. The residue was chromatographed on silica gel to give the title compound as amorphous powder (23 g, 100%). mp: 105-108 C. 1H-NMR (300 MHz, CDCl3) delta: 1.15-1.39 (6H, m), 4.09-4.39 (4H, m), 4.71 (2H, s), 4.99 (2H, s), 6.86 (2H, t, J=7.8 Hz), 7.22-7.32 (1H, m), 7.72 (2H, d, J=8.0 Hz), 8.32 (2H, d, J=8.0 Hz). IR (KBr): 1725, 1628, 1522, 1475, 1379, 1348 cm-1. FAB-Mass m/z 582 (MH+).
  • 3
  • [ 308831-94-9 ]
  • [ 34241-39-9 ]
  • [ 308831-95-0 ]
YieldReaction ConditionsOperation in experiment
100% With N-Bromosuccinimide; In tetrachloromethane; Reference Example 11 Ethyl 4-bromomethyl-2-[N-(2,6-difluorobenzyl)-N-ethoxycarbonylamino]-5-(4-nitrophenyl)thiophene-3-carboxylate A mixture of the compound obtained in Reference Example 10 (20 g, 39.64 mol), N-bromosuccinimide (7.76 g, 43.60 mol), alpha,alpha'-azobisisobutyronitrile (0.72 g, 4.36 mol) and carbon tetrachloride (300 ml) was stirred at 100 C. for 2 hours. After cooling, this reaction mixture was washed with aqueous sodium chloride solution and dried (MgSO4) and the solvent was distilled off under reduced pressure. The residue was chromatographed on silica gel to give the title compound as amorphous powder (23 g, 100%). mp: 105-108 C.; 1H-NMR (300 MHz, CDCl3) delta: 1.15-1.39 (6H, m), 4.09-4.39 (4H, m), 4.71 (2H, s), 4.99 (2H, s), 6.86 (2H, t, J=7.8 Hz), 7.22-7.32 (1H, m), 7.72 (2H, d, J=8.0 Hz), 8.32 (2H, d, J=8.0 Hz). IR (KBr): 1725, 1628, 1522, 1475, 1379, 1348 cm-1. FAB-Mass m/z 582 (MH+).
  • 4
  • [ 308831-94-9 ]
  • [ 308832-01-1 ]
  • 5
  • [ 308831-94-9 ]
  • [ 577780-07-5 ]
  • 6
  • [ 308831-94-9 ]
  • [ 737789-92-3 ]
  • 7
  • [ 308831-94-9 ]
  • [ 737789-93-4 ]
  • 8
  • [ 308831-94-9 ]
  • C31H39F2N5O7S [ No CAS ]
  • 9
  • [ 308831-94-9 ]
  • C32H41F2N5O7S [ No CAS ]
  • 10
  • [ 308831-94-9 ]
  • C30H37F2N5O7S [ No CAS ]
  • 11
  • [ 308831-94-9 ]
  • C32H41F2N5O7S [ No CAS ]
  • 12
  • [ 308831-94-9 ]
  • [ 737789-97-8 ]
  • 13
  • [ 308831-94-9 ]
  • C34H38F2N6O6S [ No CAS ]
  • 14
  • [ 308831-94-9 ]
  • C33H35F3N6O6S [ No CAS ]
  • 15
  • [ 308831-94-9 ]
  • C35H39F2N5O7S [ No CAS ]
  • 16
  • [ 308831-94-9 ]
  • C34H38F2N6O7S [ No CAS ]
  • 17
  • [ 308831-94-9 ]
  • C33H37F2N7O7S [ No CAS ]
  • 18
  • [ 308831-94-9 ]
  • 1-{4-[1-(2,6-difluorobenzyl)-3-(2-methoxyethyl)-5-[(2-methoxyethyl)(methyl)amino]methyl}-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea [ No CAS ]
  • 19
  • [ 308831-94-9 ]
  • 1-{4-[1-(2,6-difluorobenzyl)-3-(2-ethoxyethyl)-5-[(2-methoxyethyl)(methyl)amino]methyl}-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea [ No CAS ]
  • 20
  • [ 308831-94-9 ]
  • 1-{4-[1-(2,6-difluorobenzyl)-3-(2-hydroxyethyl)-5-[(2-methoxyethyl)(methyl)amino]methyl}-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea [ No CAS ]
  • 21
  • [ 308831-94-9 ]
  • 1-{4-[1-(2,6-difluorobenzyl)-3-(2-hydroxy-2-methylpropyl)-5-[(2-methoxyethyl)(methyl)amino]methyl}-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea [ No CAS ]
  • 22
  • [ 308831-94-9 ]
  • 1-{4-[1-(2,6-difluorobenzyl)-5-[(2-methoxyethyl)(methyl)amino]methyl}-2,4-dioxo-3-(pyridin-2-yl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea [ No CAS ]
  • 23
  • [ 308831-94-9 ]
  • 1-{4-[1-(2,6-difluorobenzyl)-5-[(2-methoxyethyl)(methyl)amino]methyl}-3-(5-methylpyridin-2-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea [ No CAS ]
  • 24
  • [ 308831-94-9 ]
  • 1-{4-[1-(2,6-difluorobenzyl)-3-(5-fluoropyridin-2-yl)-5-[(2-methoxyethyl)(methyl)amino]methyl}-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea [ No CAS ]
  • 25
  • [ 308831-94-9 ]
  • 1-{4-[1-(2,6-difluorobenzyl)-5-[(2-methoxyethyl)(methyl)amino]methyl}-3-(4-methoxyphenyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea [ No CAS ]
  • 26
  • [ 308831-94-9 ]
  • [ 737790-70-4 ]
  • 27
  • [ 308831-94-9 ]
  • 1-{4-[1-(2,6-difluorobenzyl)-5-[(2-methoxyethyl)(methyl)amino]methyl}-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea [ No CAS ]
  • 28
  • [ 308831-94-9 ]
  • 1-{4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea [ No CAS ]
  • 29
  • [ 308831-94-9 ]
  • TAK-385 [ No CAS ]
  • 30
  • [ 174072-89-0 ]
  • [ 308831-94-9 ]
  • 31
  • [ 308831-94-9 ]
  • [ 1589503-97-8 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: azobisisobutyronitrile; NBS / chlorobenzene / 10 h / 80 °C / Inert atmosphere 2: triethylamine / N,N-dimethyl-formamide / 2 h / 25 °C
Multi-step reaction with 2 steps 1: azobisisobutyronitrile; NBS / chlorobenzene / 10 h / 80 °C / Inert atmosphere 2: triethylamine / N,N-dimethyl-formamide / 2 h / 25 °C
Multi-step reaction with 2 steps 1: NBS; azobisisobutyronitrile / chlorobenzene / 10 h / 80 °C / Inert atmosphere 2: triethylamine / N,N-dimethyl-formamide / 2 h
Multi-step reaction with 2 steps 1: NBS / chlorobenzene / 10 h / 80 °C 2: triethylamine / N,N-dimethyl-formamide / 2 h / 25 °C
Multi-step reaction with 2 steps 1: NBS; azobisisobutyronitrile; ethyl acetate 2: triethylamine / N,N-dimethyl-formamide
Multi-step reaction with 2 steps 1: azobisisobutyronitrile; NBS / chlorobenzene / 10 h / 80 °C / Inert atmosphere; Sealed tube 2: triethylamine / N,N-dimethyl-formamide / 2 h / 25 °C / Inert atmosphere; Sealed tube
Multi-step reaction with 2 steps 1: NBS; azobisisobutyronitrile / ethyl acetate / 1 h / 50 °C 2: triethylamine / N,N-dimethyl-formamide / 1 h / 15 °C / Inert atmosphere
Multi-step reaction with 2 steps 1.1: NBS; azobisisobutyronitrile / 2 h / 80 °C 1.2: 2 h / 80 °C 2.1: hydrogenchloride; triethylamine / N,N-dimethyl-formamide

  • 32
  • [ 308831-94-9 ]
  • [ 1589503-95-6 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1: azobisisobutyronitrile; NBS / chlorobenzene / 10 h / 80 °C / Inert atmosphere 2: triethylamine / N,N-dimethyl-formamide / 2 h / 25 °C 3: potassium hydroxide / lithium hydroxide monohydrate; ethanol / 5 h / 65 °C
Multi-step reaction with 3 steps 1: azobisisobutyronitrile; NBS / chlorobenzene / 10 h / 80 °C / Inert atmosphere 2: triethylamine / N,N-dimethyl-formamide / 2 h / 25 °C 3: potassium hydroxide; lithium hydroxide monohydrate / ethanol / 5 h / 65 °C
Multi-step reaction with 3 steps 1: NBS / chlorobenzene / 10 h / 80 °C 2: triethylamine / N,N-dimethyl-formamide / 2 h / 25 °C 3: potassium hydroxide; lithium hydroxide monohydrate / ethanol / 5 h / 65 °C
Multi-step reaction with 3 steps 1: NBS; azobisisobutyronitrile / chlorobenzene / 10 h / 80 °C / Inert atmosphere 2: triethylamine / N,N-dimethyl-formamide / 2 h 3: potassium hydroxide; lithium hydroxide monohydrate / ethanol / 5 h / 65 °C
Multi-step reaction with 3 steps 1: NBS; azobisisobutyronitrile; ethyl acetate 2: triethylamine / N,N-dimethyl-formamide 3: sodium hydroxide; ethanol; lithium hydroxide monohydrate
Multi-step reaction with 3 steps 1: azobisisobutyronitrile; NBS / chlorobenzene / 10 h / 80 °C / Inert atmosphere; Sealed tube 2: triethylamine / N,N-dimethyl-formamide / 2 h / 25 °C / Inert atmosphere; Sealed tube 3: potassium hydroxide; lithium hydroxide monohydrate / ethanol / 65 °C / Inert atmosphere; Sealed tube
Multi-step reaction with 3 steps 1: NBS; azobisisobutyronitrile / chlorobenzene / 10 h / 80 °C / Inert atmosphere 2: triethylamine / N,N-dimethyl-formamide / 2 h 3: potassium hydroxide; lithium hydroxide monohydrate / ethanol / 5 h / 65 °C
Multi-step reaction with 3 steps 1: azobisisobutyronitrile; NBS / chlorobenzene / 10 h / 80 °C / Inert atmosphere; Sealed tube 2: triethylamine / N,N-dimethyl-formamide / 2 h / 25 °C / Inert atmosphere; Sealed tube 3: potassium hydroxide; lithium hydroxide monohydrate / ethanol / 5 h / 65 °C / Inert atmosphere; Sealed tube

Same Skeleton Products
Historical Records

Related Functional Groups of
[ 308831-94-9 ]

Fluorinated Building Blocks

Chemical Structure| 335410-03-2

[ 335410-03-2 ]

Methyl 5-(dipropylcarbamoyl)-2-(2-fluorobenzamido)-4-methylthiophene-3-carboxylate

Similarity: 0.71

Aryls

Chemical Structure| 335410-03-2

[ 335410-03-2 ]

Methyl 5-(dipropylcarbamoyl)-2-(2-fluorobenzamido)-4-methylthiophene-3-carboxylate

Similarity: 0.71

Amides

Chemical Structure| 335410-03-2

[ 335410-03-2 ]

Methyl 5-(dipropylcarbamoyl)-2-(2-fluorobenzamido)-4-methylthiophene-3-carboxylate

Similarity: 0.71

Esters

Chemical Structure| 335410-03-2

[ 335410-03-2 ]

Methyl 5-(dipropylcarbamoyl)-2-(2-fluorobenzamido)-4-methylthiophene-3-carboxylate

Similarity: 0.71